Prenetics Global Limited Class A (PRE)
NASDAQ: PREFinanceBlank ChecksUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PRE stock chart
Technical analysisKey statistics
All statistics- Market cap
- $171.73M
- EPS (TTM)
- -$3.10
- Dividend yield
- None
- 52-week range
- 8.69 – 27.24
- Day range
- 8.70 – 10.29
- Volume / Avg
- 593.99K / 257.57K
- Beta
- —
- Shares outstanding
- 17.93M
52-week range
PRE stock today
Prenetics Global (PRE) closed at $8.80 on Nov 20, down 14.65% (-$1.51), versus the S&P 500's 3.70% decline. Volume was 2.3x the average at 593.99K shares, a sign of unusually heavy trading. Shares are 67.7% below their 52-week high of $27.24, set on Sep 2, 2026 and 1.3% above the 52-week low of $8.69, near the bottom of the past year's range.
PRE is down 44.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 30.6%. Prenetics Global has posted a net loss over the last twelve months (EPS of -$3.10), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Prenetics Global
Company profilePrenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories.
- Sector
- Finance
- Industry
- Blank Checks
- CEO
- Mr. Sheng Wu Yeung
- Headquarters
- Quarry Bay
- Employees
- 98
- Website
- prenetics.com
Financial highlights
Full financialsIn fiscal 2024, Prenetics Global generated $30.6 million in revenue, up 40.8% from fiscal 2023, its 3rd consecutive year of revenue growth. Prenetics Global reported a net loss of $46.3 million, compared with a loss of $62.7 million a year earlier. Gross margin was 50.3% (up from 40.6%) and operating margin -157.2%.
| Fiscal year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Revenue | $30.62M | $21.74M | $13.16M | $12.53M | $65.18M |
| Growth | +40.83% | +65.17% | +5.04% | -80.77% | — |
| Net income | $-46.30M | $-62.72M | $-190.45M | $-174.01M | $-1.94M |
| EPS (diluted) | $-3.71 | $-5.58 | $-37.57 | $-178.81 | $-0.15 |
Analyst forecast
ForecastConsensus (7 analysts)
strong_buy
Avg. price target
$38.44+336.82%
- Strong buy 1
- Buy 6
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 18, 2026
- EPS actual vs est.
- $-0.93 vs $-0.73
- Surprise
- -27.40%
PRE news
All PRE news- Prenetics (PRE) Q3 2026 Earnings Call TranscriptNasdaq
- Prenetics’ IM8 Reports Q3 2026 Revenue Growth of 266% YoY; Earliest Customers Have Returned More Than 3x Their Acquisition Cost in Under Two Years; Reaffirms FY 2026 Total Revenue Guidance of $220–230 Million and FY 2027 IM8 Revenue Guidance of $400 Million+GlobeNewswire
- Prenetics’ IM8 Announces Three-Time GRAMMY-Winning DJ and Producer Diplo as IM8 Global Ambassador and Shareholder in Multi-Year PartnershipGlobeNewswire
- Prenetics’ IM8 and Authentic Brands Group Announce 10-Year Exclusive Global Partnership to Create Care Bears by IM8; Authentic to Become Strategic Shareholder in PreneticsGlobeNewswire
- Prenetics’ IM8 Names Brian J. Rosin as Successor Chief Financial OfficerGlobeNewswire
- Maxim Group Initiates Coverage of Prenetics Global at BuyNasdaq
- Lucid Capital Markets Initiates Coverage of Prenetics Global with BuyNasdaq
- IM8 Named Official Nutrition Partner of the NBA in Australia and Southeast AsiaGlobeNewswire
Prenetics Global peers
Finance sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BWIVBlue Water Acquisition Corp. IV Class A | 10.01 | -0.40% | $177.76M | vs PRE |
| CTAAClearThink 1 Acquisition Corp. Class A | 10.04 | 0.00% | $170.70M | vs PRE |
| KFIIK&F Growth Acquisition Corp. II Class A | 10.60 | 0.00% | $179.67M | vs PRE |
| ARCLARC Group Acquisition I Corp Class A | 10.04 | 0.00% | $180.05M | vs PRE |
| BEAGBold Eagle Acquisition Corp. Class A | 10.62 | 0.00% | $169.08M | vs PRE |
| OCLTOceanLight Acquisition Corporation | 10.00 | 0.00% | $168.82M | vs PRE |
| NMPNMP Acquisition Corp. Class A | 10.45 | 0.00% | $166.90M | vs PRE |
| GLEDGalaxyEdge Acquisition Corporation | 10.17 | 0.00% | $162.54M | vs PRE |
Indexes, lists and sector
Prenetics Global stock FAQ
What is Prenetics Global's stock price today?
PRE last traded at $8.80 as of Nov 20, 4:00 PM EST, down 14.65% on the day. Prices are delayed at least 15 minutes.
Does Prenetics Global pay a dividend?
No. Prenetics Global does not currently pay a regular cash dividend.
Who is Prenetics Global's CEO?
Mr. Sheng Wu Yeung is the chief executive officer of Prenetics Global Limited Class A, which has about 98 employees.
Has PRE ever split its stock?
Yes. The most recent PRE stock split was a 1-for-15 split on Nov 14, 2023, one of 2 splits on record.
What is the PRE 52-week high?
The 52-week high for PRE is $27.24 and the 52-week low is $8.69. The stock is currently 67.7% below its high.